FSNUY
FSNUY clinical trials: Fresenius SE & Co. KGaA
Every trial on ClinicalTrials.gov where Fresenius SE & Co. KGaA is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 16
- Trials linked
- 0
- As lead sponsor
- 16
- As collaborator
- 0
- Primary completions as lead sponsor, next 90 days
FSNUY on the catalyst calendar · FSNUY registry changes
- Primary completion Nov 2026Sponsor estimatePhase 2NCT07254637Tocilizumab in Chronic Inflammatory CPPD DiseaseAssistance Publique - Hôpitaux de Paris · Calcium Pyrophosphate Deposition DiseaseNot yet recruitingFSNUYCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jan 15, 2026ActualNo phase registeredNCT07565779Effect of Modifying Magnesium Concentration in Citrate-enriched Dialysate on Serum Magnesium LevelsUniversitaire Ziekenhuizen KU Leuven · Dialysis; ComplicationsCompletedFSNUYCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jan 10, 2023ActualNo phase registeredNCT05032417Evaluating the Implementation of Evidence-Based Kidney Nutrition Practice Guidelines: The AUGmeNt Study ProtocolAcademy of Nutrition and Dietetics · Chronic Kidney DiseasesUnknown statusFSNUYCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 3, 2019ActualNo phase registeredNCT03255447Peptide GAM Immunoadsorption Therapy in Autoimmune Membranous NephropathyManchester University NHS Foundation Trust · Autoimmune Membranous NephropathyCompletedFSNUYCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 2018ActualNo phase registeredNCT02787161Impact of HemoDiaFIltration on Physical Activity and Self- Reported OutcomesPontifícia Universidade Católica do Paraná · Chronic Kidney DiseaseCompletedFSNUYCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 2009ActualPhase 2NCT00326885Study of the Trifunctional Antibody Catumaxomab to Treat Recurrent Symptomatic Malignant AscitesNeovii Biotech · Malignant AscitesCompletedFSNUYCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Aug 2015Sponsor estimatePhase 2NCT01810926T&B Depletion Non MalignantFranco Locatelli · Graft Versus Host DiseaseUnknown statusFSNUYCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Feb 2008ActualPhase 2NCT00377429Safety and Efficacy Study of Catumaxomab to Treat Ovarian Cancer After a Complete Response to ChemotherapyNeovii Biotech · Ovarian CancerCompletedFSNUYCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 2010ActualPhase 4NCT00273728BaSES Trial: Basel Starch Evaluation in SepsisUniversity Hospital, Basel, Switzerland · SepsisCompletedFSNUYCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 2009ActualPhase 2NCT00522457Phase II Study With the Trifunctional Antibody Ertumaxomab to Treat Metastatic Breast Cancer After Progression on Trastuzumab TherapyNeovii Biotech · Metastatic Breast CancerTerminatedFSNUYCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jan 2004ActualPhase 2NCT00919659Parenteral Nutrition Support for Patients With Pancreatic CancerCONKO-Studiengruppe · Cancer CachexiaCompletedFSNUYCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 2009Sponsor estimatePhase 2NCT00436722Induction Treatment Followed by Immunosuppression Withdrawal in Liver Transplantation: A Comparative TrialHospital Clinic of Barcelona · Liver DiseasesTerminatedFSNUYCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Not registeredNo phase registeredNCT00135044A Trial of Taurine Supplementation in Parenteral Nutrition 1London North West Healthcare NHS Trust · CholestasisUnknown statusFSNUYCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Not registeredPhase 4NCT00529139Hannover Dialysis Outcome StudyHannover Medical School · Acute Kidney FailureCompletedFSNUYCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Not registeredNo phase registeredNCT00150891Th1, Th2 and Monokine Responses as Risk Factors of Renal Transplant RejectionUniversity of Giessen · Renal Failure, ChronicCompletedFSNUYCollaboratorNVSCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Not registeredPhase 4NCT00142220The Benefit of Adding Fish Oil to the Nutrition of Critically Ill PatientsUniversity Medicine Greifswald · Sepsis SyndromeCompletedFSNUYCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 16 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScanner